Express Scripts Holding Co. (NASDAQ:ESRX)’s share price was down 4.3% during mid-day trading on Thursday . The stock traded as low as $72.99 and last traded at $73.02, with a volume of 6,163,307 shares trading hands. The stock had previously closed at $76.34.

Several equities analysts have recently issued reports on ESRX shares. Morgan Stanley lowered shares of Express Scripts Holding from an “equal weight” rating to an “underweight” rating and boosted their price target for the company from $67.00 to $70.00 in a report on Monday, June 20th. Cowen and Company reissued a “positive” rating and issued a $83.00 price target on shares of Express Scripts Holding in a report on Wednesday, June 15th. Zacks Investment Research lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Tuesday, July 19th. Bank of America Corp. reissued a “neutral” rating and issued a $82.00 price target on shares of Express Scripts Holding in a report on Tuesday, June 7th. Finally, Jefferies Group decreased their price target on shares of Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating for the company in a report on Tuesday, July 26th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Express Scripts Holding currently has an average rating of “Hold” and a consensus price target of $81.26.

The company has a market cap of $45.57 billion and a price-to-earnings ratio of 17.87. The company’s 50-day moving average price is $76.98 and its 200 day moving average price is $73.35.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.57. During the same quarter in the prior year, the business earned $1.44 earnings per share. The business had revenue of $25.20 billion for the quarter, compared to analyst estimates of $25.42 billion. The firm’s quarterly revenue was down .9% compared to the same quarter last year. Equities research analysts forecast that Express Scripts Holding Co. will post $6.38 earnings per share for the current year.

Other hedge funds and institutional investors have modified their holdings of the company. Suntrust Banks Inc. boosted its position in shares of Express Scripts Holding by 0.4% in the fourth quarter. Suntrust Banks Inc. now owns 185,177 shares of the company’s stock worth $16,184,000 after buying an additional 803 shares in the last quarter. Parsons Capital Management Inc. RI boosted its position in shares of Express Scripts Holding by 1.0% in the fourth quarter. Parsons Capital Management Inc. RI now owns 33,337 shares of the company’s stock worth $2,914,000 after buying an additional 345 shares in the last quarter. Pittenger & Anderson Inc. boosted its position in shares of Express Scripts Holding by 2.0% in the fourth quarter. Pittenger & Anderson Inc. now owns 42,971 shares of the company’s stock worth $3,756,000 after buying an additional 850 shares in the last quarter. Bronfman E.L. Rothschild L.P. acquired a new position in shares of Express Scripts Holding during the fourth quarter worth about $1,316,000. Finally, Trexquant Investment LP acquired a new position in shares of Express Scripts Holding during the fourth quarter worth about $1,941,000.

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.